Johnson & Johnson ($JNJ) Earnings (Q1 FY22)

Johnson & Johnson ($JNJ) Earnings and Opinion:


Johnson & Johnson is a company in the Healthcare sector and operates in the Drug Manufactures-General industry. The company manufactures and sells various health products worldwide. Johnson & Johnson was founded in 1886 and is currently headquartered in New Brunswick, New Jersey. The stock saw its first day on the stock market in 1944. 

Johnson & Johnson EPS and Revenue (Q1 FY22):

  • EPS of $2.67 beating expectations of $2.59
  • Revenue of 23.43B missing expectations of $23.79B
  • EPS was up 3.1% (YOY) and Revenue was up 5% (YOY)
Johnson & Johnson Q1 Highlights:
  • Operational growth of 7.7%
  • Suspending Covid-19 vaccine sales guidance
  • Maintaining full year 2022 guidance
Johnson & Johnson Dividend Information:
  • Increased dividend for the 60th consecutive year
  • Dividend increase of 6.6%
  • Quarterly dividend of $1.13 a share now
Opinion:
Johnson & Johnson is currently trading higher during todays session despite missing on revenue expectations and narrowly beating EPS estimates. In some big news with the company, they are no longer providing sales guidance anymore for Covid-19 vaccine sales. The company also trimmed profits in claims that they are facing currency headwinds. However, one thing that is inching the stock higher today would be the dividend increase announced. The company was able to increase its dividend for the 60th year in a row. This brings a ton of joy to dividend growth investors and basically is an income generating stock for those that got into this company early. Overall, looking at the financials, it seems J&J has a little bit of work to do, especially since they are cutting the vaccine guidance. They didn't perform too hot compared to Pfizer and Moderna in that category, but has a lot of headway on other projects they are currently working on to make them a bunch of money. I like how they were still able to increase sales on a year to year basis and they are evidently building their net income if they are able to increase their dividend payouts to shareholders. I am in love with this stock even though I have no holdings. The dividend is one of the key things that stand out to me. You can see the endless potential to gain some nice returns on this stock just from dividend payouts and reinvestments. I would jump on this stock as soon as you can, because I see no signs of stopping for them. 

*Information from Johnson & Johnson, Yahoo Finance, and Nasdaq
*Estimates attained from Zacks

Comments

Post a Comment

Popular posts from this blog

Weekly Earnings Review: September 25, 2023- September 29, 2023

     It was a nice little break in the earnings report, but just like that we are back! We are slowly easing our way back into earnings season. However, this week marked the end of Q3 and September. September was a downturn from the rally we saw earlier in the year. There is a lot of stuff looming as the government is set to shut down on October 1st. The Fed is keeping a close eye on inflation but this weeks prints showed some signs of improvement. The average consumer is struggling as savings keep dwindling. In terms of our earnings, we just had two companies that reported this week. One is a warehouse style retailer and the other is a wide range consulting firm.  Tuesday, September 26, 2023 Costco Wholesale Corporation (COST)-     Costco beat expectations on both the top and bottom line. The stock saw a decline after the initial earnings report, but by the end of the week it has hit a new 52-week high. The revenue growth was impressive as it grew by a hair under 10%. The COGS growth
Read more

Weekly Earnings Review: October 16, 2023- October 20, 2023

      Well earnings season is finally among us, so we will start producing more beefier blog posts and cover a lot more companies over these next few weeks. I had one company report last week that I decided to throw into this weeks post, because I felt that it was pointless to make a post with just one boring company. With the inclusion of that company, we will cover 7 companies that report earnings this week and will give your our thoughts and opinions on how they performed during the quarter and the outlook. There is a lot of controversy going on with a war breaking out in Israel and the House of Representatives with out a speaker. This year seems to be the year of how geopolitics affect the market. There seems to be a lot of confusion with the outlook of the market right now, but inflation numbers still look to be fair and the earnings of major companies will be able to tell us a little bit more about where this is headed.  Thursday, October 12, 2023 Walgreens Boots Alliance (WBA)-
Read more

Weekly Earnings Review: November 27, 2023- December 1, 2023

Image
     Stocks continue to rise as we enter the final month of trading for the year. The S&P 500 and Nasdaq had another stellar month. Bond yields continue to fall, as interest rates have seemed to reach their peak. Estimates are all over the place when it comes to when cutting will start and how many cuts we will see next year. I added a new mantra to particular companies. I want to add some visual pieces to the post to entice the readers. Hope you guys enjoy the visuals and the excerpts. Stay investing! Monday, November 27, 2023 Zscaler (ZS)-      Zscaler continues to carry its momentum, as the company beat on both the top and bottom lines. The company achieved 40% growth on the top line and saw impressive growth on the bottom line as well. Management raised guidance and are expecting around 30% growth on both the top and bottom line. What is so impressive about this company is that they are achieving high growth and high profitability. This is a feat that a lot of software companie
Read more